Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Benefits of Early Hemoglobin Response to Epoetin Alfa in Elderly Patients with Chemotherapy-Related Anemia.

James Rosberg, PhD, MBA, Pierre Y. Cremieux, PhD, Scott R. McKenzie, MD, John M. Fastenau, MPH, RPh, Catherine T. Piech, MBA

Blood (2004) 104 (11): 2216.

https://doi.org/10.1182/blood.V104.11.2216.2216

Published: 2004

Journal Articles

Greater Area under the Hemoglobin Change Curve Is Associated with Improved Outcomes in Elderly Patients Receiving Epoetin Alfa for Chemotherapy-Related Anemia.

Scott R. McKenzie, MD, Mei S. Duh, MPH, ScD, Patrick Lefevbre, MA, John M. Fastenau, MPH, RPh, Catherine Tak Piech, MBA

Blood (2004) 104 (11): 3146.

https://doi.org/10.1182/blood.V104.11.3146.3146

Published: 2004

Journal Articles

Dosing Patterns of Erythropoietic Agents and Their Association with Provider Visits in Patients with Cancer and Anemia.

Susan C. Bolge, PhD, John M. Fastenau, MPH, RPh, Jamie B. Howell, PharmD, MS, Catherine T. Piech, MBA, Jane A. Donohue, PhD

Blood (2004) 104 (11): 5306.

https://doi.org/10.1182/blood.V104.11.5306.5306

Published: 2004

Journal Articles

Early Results from a Choice Based Conjoint Analysis Assessing Patient Preferences for Selected Features of Erythropoietic Agents.

Susan C. Bolge, PhD, John M. Fastenau, MPH, RPh, Jamie B. Howell, PharmD, MS, Catherine T. Piech, MBA, Jane A. Donohue, PhD

Blood (2004) 104 (11): 5307.

https://doi.org/10.1182/blood.V104.11.5307.5307

Published: 2004

Journal Articles

Utilization Trends of Epoetin Alfa and Darbepoetin Alfa in Adult Patients with Cancer Receiving Chemotherapy in Community Practice Settings.

Ted Coletti, PhD, Jamie B. Howell, PharmD, MS, Karen Todoroff, MPH, Keith L. Gregory, PhD, John M. Fastenau, MPH, RPh

Blood (2004) 104 (11): 5313.

https://doi.org/10.1182/blood.V104.11.5313.5313

Published: 2004

NARROW

Benefits of Early Hemoglobin Response to Epoetin Alfa in Elderly Patients with Chemotherapy-Related Anemia.

Greater Area under the Hemoglobin Change Curve Is Associated with Improved Outcomes in Elderly Patients Receiving Epoetin Alfa for Chemotherapy-Related Anemia.

Dosing Patterns of Erythropoietic Agents and Their Association with Provider Visits in Patients with Cancer and Anemia.

Early Results from a Choice Based Conjoint Analysis Assessing Patient Preferences for Selected Features of Erythropoietic Agents.

Utilization Trends of Epoetin Alfa and Darbepoetin Alfa in Adult Patients with Cancer Receiving Chemotherapy in Community Practice Settings.

Email alerts

ASH Publications

American Society of Hematology

Benefits of Early Hemoglobin Response to Epoetin Alfa in Elderly Patients with Chemotherapy-Related Anemia.

Greater Area under the Hemoglobin Change Curve Is Associated with Improved Outcomes in Elderly Patients Receiving Epoetin Alfa for Chemotherapy-Related Anemia.

Dosing Patterns of Erythropoietic Agents and Their Association with Provider Visits in Patients with Cancer and Anemia.

Early Results from a Choice Based Conjoint Analysis Assessing Patient Preferences for Selected Features of Erythropoietic Agents.

Utilization Trends of Epoetin Alfa and Darbepoetin Alfa in Adult Patients with Cancer Receiving Chemotherapy in Community Practice Settings.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only